PhotonPharma Inc. Announces Recruitment for Phase 1 Clinical Trial of Innocell™ Autologous Cellular Immunotherapy for Recurren

No Result

View All Result

No Result

View All Result

Home Author

Cision PR Newswire

Health & Fitness

PhotonPharma Inc. Announces Recruitment for Phase 1 Clinical Trial of Innocell™ Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer

February 5, 2026

Health & Fitness

Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

February 5, 2026

Health & Fitness

The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend

February 5, 2026

Tech

Brand Engagement Network Terminates $50 Million Standby Equity Purchase Agreement, Strengthening Balance Sheet and Reducing Potential Dilution

February 5, 2026

Tech

Gabriel Marketing Group Named a Top B2B Tech Public Relations Firm in Washington, D.C. by Expertise.com

February 5, 2026

Tech

Coldstream Continues Strategic Expansion in the Pacific Northwest with New Office and Team in Bend, Oregon

February 5, 2026

Tech

APEXX Global Announces $10 million Investment from Finch Capital to Accelerate Global Growth

February 5, 2026

Health & Fitness

Delta Dental publishes new white paper with actionable strategies to strengthen the oral health workforce through early exposure programs

February 5, 2026

Food & Drink

Tanmiah Partners with PHYLA and RECYCLEE to Bolster Circular Economy and Food Security

February 5, 2026

Tech

76% of women change their behaviour after dark in winter to feel safe

February 5, 2026

Page 5 of 604 Prev 1 … 4 5 6 … 604 Next

About

About Us

We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc. Check our landing page for details.

No Result

View All Result

Cision PR Newswire

PhotonPharma Inc. Announces Recruitment for Phase 1 Clinical Trial of Innocell™ Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer

Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website

The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend

Brand Engagement Network Terminates $50 Million Standby Equity Purchase Agreement, Strengthening Balance Sheet and Reducing Potential Dilution

Gabriel Marketing Group Named a Top B2B Tech Public Relations Firm in Washington, D.C. by Expertise.com

Coldstream Continues Strategic Expansion in the Pacific Northwest with New Office and Team in Bend, Oregon

APEXX Global Announces $10 million Investment from Finch Capital to Accelerate Global Growth

Delta Dental publishes new white paper with actionable strategies to strengthen the oral health workforce through early exposure programs

Tanmiah Partners with PHYLA and RECYCLEE to Bolster Circular Economy and Food Security

76% of women change their behaviour after dark in winter to feel safe

Recommended

ANGHAMI REPORTS H1 2025 FINANCIAL RESULTS; MARKED BY TOPLINE GROWTH AND TRANSFORMATIVE DEAL WITH WARNER BROS. DISCOVERY

Hadrian Launches Additive Manufacturing Division to Expand U.S. Defense Production Capacity

Popular News

Global Opportunities Trust Plc – Net Asset Value(s)

Cold Spring Harbor Laboratory Researchers Find New Way to Slow Memory Loss in Alzheimer’s

Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

Natural Grocers® Celebrates Iowa Day with a Special Gift and Savings Feb. 8-10, 2026

Best of 2026: Cars.com Names Nissan Leaf Top Vehicle of the Year

Connect with us

Topics

About

About Us